treatment
-
Spine
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans
Surgeons Will Determine Their Surgical Treatment Plan Before Nociscan and Report on How Often the Surgical Plan Changes After Receiving…
Read More » -
Spine
New4med GmbH Announces First Cases of its novel Basivertebral Nerve Ablation (BVNA)
LADENBURG, Germany, July 8, 2024 /PRNewswire/ — New4med GmbH, a German startup focused on innovative spinal treatments, announces the successful European market launch of…
Read More » -
Spine
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitation Norway is a single-payer…
Read More » -
Recon
Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System
Patients Have been Successfully Enrolled in Both US and European Clinical Studies LEXINGTON, Mass., April 21, 2024 /PRNewswire/ — Hyalex Orthopaedics, a privately held…
Read More » -
Financial
Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
MINNEAPOLIS, April 20, 2023 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic…
Read More » -
Spine
Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor
Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is…
Read More » -
Spine
ATEC Advances Lateral Sophistication
Innovation designed to expand lateral adoption and improve patient outcomes October 11, 2022 CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC),…
Read More » -
Extremities
Bioretec’s ActivaPin™ bioresorbable implant provides good alternative treatment of pediatric elbow injuries
TAMPERE, Finland, Aug. 23, 2022 /PRNewswire/ — A recently published clinical study confirms the benefits of using fully bioresorbable ActivaPin™ implant together…
Read More » -
Biologics
Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis
ATLANTA , June 10, 2022 /PRNewswire/ — Lipogems is pleased to announce the unconditional approval by the U.S. Food and Drug Administration (FDA) to…
Read More » -
Biologics
First Subjects Randomized and Dosed in the U.S. under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OA
Ongoing trial to assess the potential of Zilosul™ to address unmet medical need in OA which affects more than 72 million…
Read More » -
Financial
Rotator Cuff Injury Treatment Market by Modality, Physiotherapy, Drug Therapeutics and Region – Global Forecast to 2026 – ResearchAndMarkets.com
April 27, 2022 DUBLIN–(BUSINESS WIRE)–The “Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold…
Read More »